protocol 3-aml-83 , representing the third period , included a four-week induction phase with vincristine , adriamycin , cytosine-arabinoside , prednisone and 6-mercaptopurine , followed by a consolidation phase with cyclophosphamide , cytosine-arabinoside and 6-mercaptopurine for four weeks .
C0023467
aml
C0010583
cyclophosphamide